You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

155 Results
Guidelines and Advice
Status: Current
ID: pet 2016-1
Nov 2016
Statistical Reports
Jun 2016
Statistical Reports
 
Aug 2016
Guidelines and Advice
Status: Current
ID: GL-C50-25
Feb 2016
Guidelines and Advice
Status: Current
ID: GL-C50-28
Dec 2016
Drug
Other Name(s): Megace® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2016
Drug
Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2016
Drug
Other Name(s): Zoladex® (AstraZeneca) , Zoladex® LA (AstraZeneca)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Mar 2016
Drug
Other Name(s): Ifex® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2016
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
aldesleukin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2019
Regimen
Cancer Type:
Genitourinary, 
Testis
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
etoposide,
CISplatin,
ifosfamide,
mesna
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2016
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
PACLitaxel,
CISplatin,
etoposide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2019

Pages